Effects of Norethisterone on Endometrial Abnormalities in Post-Menopausal Women on Tamoxifen
Author Information
Author(s): TJ Powles, T Bourne, S Athanasiou, J Chang, K Grubock, S Ashley, L Oakes, A Tidyl, J Davey, J Viggers, S Humphries, W Collins
Primary Institution: Royal Marsden Hospital
Hypothesis
Does norethisterone help reduce endometrial abnormalities in post-menopausal women taking tamoxifen?
Conclusion
The study found that while norethisterone did not reverse endometrial abnormalities, most women experienced withdrawal bleeding, indicating an oestrogenically primed endometrium.
Supporting Evidence
- 24% of women on tamoxifen had persistent endometrial thickening compared to 2% on placebo.
- 15% of women on tamoxifen had cystic changes and 11% had polyps.
- 96% of women on tamoxifen experienced withdrawal bleeding after norethisterone treatment.
Takeaway
This study looked at women taking tamoxifen and found that many had changes in their uterus, but a medicine called norethisterone didn't fix those changes.
Methodology
The study involved regular transvaginal ultrasound screenings and the administration of norethisterone to women with identified endometrial thickening.
Potential Biases
Potential observer bias in ultrasound assessments and histological evaluations.
Limitations
The study had a small sample size and relied on ultrasound findings without adequate histological confirmation for all participants.
Participant Demographics
Post-menopausal women, median age 57, with a family history of breast cancer.
Statistical Information
P-Value
<0.0005
Statistical Significance
p<0.0005
Want to read the original?
Access the complete publication on the publisher's website